Multiple Sclerosis Clinical Trials in Kansas

13 recruiting studies across 11 cities

All Trials in Kansas

Phase
Trial Phase Location
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1Fairway
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisPhase 3Kansas City
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisPhase 3Kansas City
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis SpasticityPhase 2Kansas City
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyPhase 1/2Kansas City
Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote NeuroprotectionPhase 2Kansas City
Dry Needling in Multiple SclerosisN/AKansas City
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Phase 3Kansas City
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 2Kansas City
Treatment of Participants With Primary or Secondary Progressive Multiple SclerosisPhase 1/2Kansas City
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabPhase 3Overland Park
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—Roeland Park
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisPhase 3Roeland Park

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.